Response to: monoclonal antibodies targeting CD20

MAbs. 2013 May-Jun;5(3):337-8. doi: 10.4161/mabs.24108. Epub 2013 Mar 14.

Authors

Christian Klein¹, Alfred Lammens², Wolfgang Schäfer³, Guy Georges³, Manfred Schwaiger⁴, Ekkehard Mössner¹, Karl-Peter Hopfner², Pablo Umaña¹, Gerhard Niederfellner⁴

Affiliations

¹ Discovery Oncology; Pharma Research and Early Development (pRED); Roche Glycart AG; Schlieren, Switzerland.
² Department of Chemistry and Biochemistry; Gene Center; Ludwig-Maximilians University Munich; Munich, Germany.
³ Large Molecule Research; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany.
⁴ Discovery Oncology; Pharma Research and Early Development (pRED); Roche Diagnostics GmbH; Penzberg, Germany.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Antibodies, Monoclonal / metabolism*
Antigens, CD20 / metabolism*
Epitopes / metabolism*
Humans

Substances

Antibodies, Monoclonal
Antigens, CD20
Epitopes